Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Genomics In Cancer Care Market, by Application
1.4.2 Global Genomics In Cancer Care Market, by Product
1.4.3 Global Genomics In Cancer Care Market, by Technology
1.4.4 Global Genomics In Cancer Care Market, by Geography
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
Chapter 4. Competition Analysis - Global
4.1 KBV Cardinal Matrix
4.2 Recent Industry Wide Strategic Developments
4.2.1 Partnerships, Collaborations and Agreements
4.2.2 Product Launches and Product Expansions
4.2.3 Acquisition and Mergers
4.3 Market Share Analysis, 2023
4.4 Top Winning Strategies
4.4.1 Key Leading Strategies: Percentage Distribution (2020-2024)
4.4.2 Key Strategic Move: (Mergers and Acquisitions: 2021, Jan – 2023, Jan) Leading Players
4.5 Porter Five Forces Analysis
Chapter 5. Global Genomics In Cancer Care Market by Application
5.1 Global Diagnostics Market by Region
5.2 Global Personalized Medicine Market by Region
5.3 Global Drug Discovery & Development Market by Region
5.4 Global Research Market by Region
Chapter 6. Global Genomics In Cancer Care Market by Product
6.1 Global Instruments Market by Region
6.2 Global Consumables Market by Region
6.3 Global Services Market by Region
Chapter 7. Global Genomics In Cancer Care Market by Technology
7.1 Global PCR Market by Region
7.2 Global Genome Sequencing Market by Region
7.3 Global Microarrays Market by Region
7.4 Global Nuclei Acid Extraction & Purification Market by Region
7.5 Global Others Market by Region
Chapter 8. Global Genomics In Cancer Care Market by Region
8.1 North America Genomics In Cancer Care Market
8.1.1 North America Genomics In Cancer Care Market by Application
8.1.1.1 North America Diagnostics Market by Country
8.1.1.2 North America Personalized Medicine Market by Country
8.1.1.3 North America Drug Discovery & Development Market by Country
8.1.1.4 North America Research Market by Country
8.1.2 North America Genomics In Cancer Care Market by Product
8.1.2.1 North America Instruments Market by Country
8.1.2.2 North America Consumables Market by Country
8.1.2.3 North America Services Market by Country
8.1.3 North America Genomics In Cancer Care Market by Technology
8.1.3.1 North America PCR Market by Country
8.1.3.2 North America Genome Sequencing Market by Country
8.1.3.3 North America Microarrays Market by Country
8.1.3.4 North America Nuclei Acid Extraction & Purification Market by Country
8.1.3.5 North America Others Market by Country
8.1.4 North America Genomics In Cancer Care Market by Country
8.1.4.1 US Genomics In Cancer Care Market
8.1.4.1.1 US Genomics In Cancer Care Market by Application
8.1.4.1.2 US Genomics In Cancer Care Market by Product
8.1.4.1.3 US Genomics In Cancer Care Market by Technology
8.1.4.2 Canada Genomics In Cancer Care Market
8.1.4.2.1 Canada Genomics In Cancer Care Market by Application
8.1.4.2.2 Canada Genomics In Cancer Care Market by Product
8.1.4.2.3 Canada Genomics In Cancer Care Market by Technology
8.1.4.3 Mexico Genomics In Cancer Care Market
8.1.4.3.1 Mexico Genomics In Cancer Care Market by Application
8.1.4.3.2 Mexico Genomics In Cancer Care Market by Product
8.1.4.3.3 Mexico Genomics In Cancer Care Market by Technology
8.1.4.4 Rest of North America Genomics In Cancer Care Market
8.1.4.4.1 Rest of North America Genomics In Cancer Care Market by Application
8.1.4.4.2 Rest of North America Genomics In Cancer Care Market by Product
8.1.4.4.3 Rest of North America Genomics In Cancer Care Market by Technology
8.2 Europe Genomics In Cancer Care Market
8.2.1 Europe Genomics In Cancer Care Market by Application
8.2.1.1 Europe Diagnostics Market by Country
8.2.1.2 Europe Personalized Medicine Market by Country
8.2.1.3 Europe Drug Discovery & Development Market by Country
8.2.1.4 Europe Research Market by Country
8.2.2 Europe Genomics In Cancer Care Market by Product
8.2.2.1 Europe Instruments Market by Country
8.2.2.2 Europe Consumables Market by Country
8.2.2.3 Europe Services Market by Country
8.2.3 Europe Genomics In Cancer Care Market by Technology
8.2.3.1 Europe PCR Market by Country
8.2.3.2 Europe Genome Sequencing Market by Country
8.2.3.3 Europe Microarrays Market by Country
8.2.3.4 Europe Nuclei Acid Extraction & Purification Market by Country
8.2.3.5 Europe Others Market by Country
8.2.4 Europe Genomics In Cancer Care Market by Country
8.2.4.1 Germany Genomics In Cancer Care Market
8.2.4.1.1 Germany Genomics In Cancer Care Market by Application
8.2.4.1.2 Germany Genomics In Cancer Care Market by Product
8.2.4.1.3 Germany Genomics In Cancer Care Market by Technology
8.2.4.2 UK Genomics In Cancer Care Market
8.2.4.2.1 UK Genomics In Cancer Care Market by Application
8.2.4.2.2 UK Genomics In Cancer Care Market by Product
8.2.4.2.3 UK Genomics In Cancer Care Market by Technology
8.2.4.3 France Genomics In Cancer Care Market
8.2.4.3.1 France Genomics In Cancer Care Market by Application
8.2.4.3.2 France Genomics In Cancer Care Market by Product
8.2.4.3.3 France Genomics In Cancer Care Market by Technology
8.2.4.4 Russia Genomics In Cancer Care Market
8.2.4.4.1 Russia Genomics In Cancer Care Market by Application
8.2.4.4.2 Russia Genomics In Cancer Care Market by Product
8.2.4.4.3 Russia Genomics In Cancer Care Market by Technology
8.2.4.5 Spain Genomics In Cancer Care Market
8.2.4.5.1 Spain Genomics In Cancer Care Market by Application
8.2.4.5.2 Spain Genomics In Cancer Care Market by Product
8.2.4.5.3 Spain Genomics In Cancer Care Market by Technology
8.2.4.6 Italy Genomics In Cancer Care Market
8.2.4.6.1 Italy Genomics In Cancer Care Market by Application
8.2.4.6.2 Italy Genomics In Cancer Care Market by Product
8.2.4.6.3 Italy Genomics In Cancer Care Market by Technology
8.2.4.7 Rest of Europe Genomics In Cancer Care Market
8.2.4.7.1 Rest of Europe Genomics In Cancer Care Market by Application
8.2.4.7.2 Rest of Europe Genomics In Cancer Care Market by Product
8.2.4.7.3 Rest of Europe Genomics In Cancer Care Market by Technology
8.3 Asia Pacific Genomics In Cancer Care Market
8.3.1 Asia Pacific Genomics In Cancer Care Market by Application
8.3.1.1 Asia Pacific Diagnostics Market by Country
8.3.1.2 Asia Pacific Personalized Medicine Market by Country
8.3.1.3 Asia Pacific Drug Discovery & Development Market by Country
8.3.1.4 Asia Pacific Research Market by Country
8.3.2 Asia Pacific Genomics In Cancer Care Market by Product
8.3.2.1 Asia Pacific Instruments Market by Country
8.3.2.2 Asia Pacific Consumables Market by Country
8.3.2.3 Asia Pacific Services Market by Country
8.3.3 Asia Pacific Genomics In Cancer Care Market by Technology
8.3.3.1 Asia Pacific PCR Market by Country
8.3.3.2 Asia Pacific Genome Sequencing Market by Country
8.3.3.3 Asia Pacific Microarrays Market by Country
8.3.3.4 Asia Pacific Nuclei Acid Extraction & Purification Market by Country
8.3.3.5 Asia Pacific Others Market by Country
8.3.4 Asia Pacific Genomics In Cancer Care Market by Country
8.3.4.1 China Genomics In Cancer Care Market
8.3.4.1.1 China Genomics In Cancer Care Market by Application
8.3.4.1.2 China Genomics In Cancer Care Market by Product
8.3.4.1.3 China Genomics In Cancer Care Market by Technology
8.3.4.2 Japan Genomics In Cancer Care Market
8.3.4.2.1 Japan Genomics In Cancer Care Market by Application
8.3.4.2.2 Japan Genomics In Cancer Care Market by Product
8.3.4.2.3 Japan Genomics In Cancer Care Market by Technology
8.3.4.3 India Genomics In Cancer Care Market
8.3.4.3.1 India Genomics In Cancer Care Market by Application
8.3.4.3.2 India Genomics In Cancer Care Market by Product
8.3.4.3.3 India Genomics In Cancer Care Market by Technology
8.3.4.4 South Korea Genomics In Cancer Care Market
8.3.4.4.1 South Korea Genomics In Cancer Care Market by Application
8.3.4.4.2 South Korea Genomics In Cancer Care Market by Product
8.3.4.4.3 South Korea Genomics In Cancer Care Market by Technology
8.3.4.5 Singapore Genomics In Cancer Care Market
8.3.4.5.1 Singapore Genomics In Cancer Care Market by Application
8.3.4.5.2 Singapore Genomics In Cancer Care Market by Product
8.3.4.5.3 Singapore Genomics In Cancer Care Market by Technology
8.3.4.6 Malaysia Genomics In Cancer Care Market
8.3.4.6.1 Malaysia Genomics In Cancer Care Market by Application
8.3.4.6.2 Malaysia Genomics In Cancer Care Market by Product
8.3.4.6.3 Malaysia Genomics In Cancer Care Market by Technology
8.3.4.7 Rest of Asia Pacific Genomics In Cancer Care Market
8.3.4.7.1 Rest of Asia Pacific Genomics In Cancer Care Market by Application
8.3.4.7.2 Rest of Asia Pacific Genomics In Cancer Care Market by Product
8.3.4.7.3 Rest of Asia Pacific Genomics In Cancer Care Market by Technology
8.4 LAMEA Genomics In Cancer Care Market
8.4.1 LAMEA Genomics In Cancer Care Market by Application
8.4.1.1 LAMEA Diagnostics Market by Country
8.4.1.2 LAMEA Personalized Medicine Market by Country
8.4.1.3 LAMEA Drug Discovery & Development Market by Country
8.4.1.4 LAMEA Research Market by Country
8.4.2 LAMEA Genomics In Cancer Care Market by Product
8.4.2.1 LAMEA Instruments Market by Country
8.4.2.2 LAMEA Consumables Market by Country
8.4.2.3 LAMEA Services Market by Country
8.4.3 LAMEA Genomics In Cancer Care Market by Technology
8.4.3.1 LAMEA PCR Market by Country
8.4.3.2 LAMEA Genome Sequencing Market by Country
8.4.3.3 LAMEA Microarrays Market by Country
8.4.3.4 LAMEA Nuclei Acid Extraction & Purification Market by Country
8.4.3.5 LAMEA Others Market by Country
8.4.4 LAMEA Genomics In Cancer Care Market by Country
8.4.4.1 Brazil Genomics In Cancer Care Market
8.4.4.1.1 Brazil Genomics In Cancer Care Market by Application
8.4.4.1.2 Brazil Genomics In Cancer Care Market by Product
8.4.4.1.3 Brazil Genomics In Cancer Care Market by Technology
8.4.4.2 Argentina Genomics In Cancer Care Market
8.4.4.2.1 Argentina Genomics In Cancer Care Market by Application
8.4.4.2.2 Argentina Genomics In Cancer Care Market by Product
8.4.4.2.3 Argentina Genomics In Cancer Care Market by Technology
8.4.4.3 UAE Genomics In Cancer Care Market
8.4.4.3.1 UAE Genomics In Cancer Care Market by Application
8.4.4.3.2 UAE Genomics In Cancer Care Market by Product
8.4.4.3.3 UAE Genomics In Cancer Care Market by Technology
8.4.4.4 Saudi Arabia Genomics In Cancer Care Market
8.4.4.4.1 Saudi Arabia Genomics In Cancer Care Market by Application
8.4.4.4.2 Saudi Arabia Genomics In Cancer Care Market by Product
8.4.4.4.3 Saudi Arabia Genomics In Cancer Care Market by Technology
8.4.4.5 South Africa Genomics In Cancer Care Market
8.4.4.5.1 South Africa Genomics In Cancer Care Market by Application
8.4.4.5.2 South Africa Genomics In Cancer Care Market by Product
8.4.4.5.3 South Africa Genomics In Cancer Care Market by Technology
8.4.4.6 Nigeria Genomics In Cancer Care Market
8.4.4.6.1 Nigeria Genomics In Cancer Care Market by Application
8.4.4.6.2 Nigeria Genomics In Cancer Care Market by Product
8.4.4.6.3 Nigeria Genomics In Cancer Care Market by Technology
8.4.4.7 Rest of LAMEA Genomics In Cancer Care Market
8.4.4.7.1 Rest of LAMEA Genomics In Cancer Care Market by Application
8.4.4.7.2 Rest of LAMEA Genomics In Cancer Care Market by Product
8.4.4.7.3 Rest of LAMEA Genomics In Cancer Care Market by Technology
Chapter 9. Company Profiles
9.1 Agilent Technologies, Inc.
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expense
9.1.5 Recent strategies and developments:
9.1.5.1 Acquisition and Mergers:
9.1.6 SWOT Analysis
9.2 F. Hoffmann-La Roche Ltd.
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.2.5 Recent strategies and developments:
9.2.5.1 Partnerships, Collaborations, and Agreements:
9.2.5.2 Product Launches and Product Expansions:
9.2.6 SWOT Analysis
9.3 Danaher Corporation (Beckman Coulter, Inc.)
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expense
9.3.5 Recent strategies and developments:
9.3.5.1 Partnerships, Collaborations, and Agreements:
9.3.6 SWOT Analysis
9.4 Abbott Laboratories
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Research & Development Expense
9.4.5 SWOT Analysis
9.5 Bio-Rad laboratories, Inc.
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expenses
9.5.5 Recent strategies and developments:
9.5.5.1 Partnerships, Collaborations, and Agreements:
9.5.5.2 Product Launches and Product Expansions:
9.5.6 SWOT Analysis
9.6 GE HealthCare Technologies, Inc.
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segmental and Regional Analysis
9.6.4 Research & Development Expenses
9.6.5 Recent strategies and developments:
9.6.5.1 Partnerships, Collaborations, and Agreements:
9.6.6 SWOT Analysis
9.7 Quest Diagnostics Incorporated
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental Analysis
9.7.4 SWOT Analysis
9.8 Revvity, Inc.
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Segmental and Regional Analysis
9.8.4 Research & Development Expenses
9.8.5 Recent strategies and developments:
9.8.5.1 Acquisition and Mergers:
9.8.6 SWOT Analysis
9.9 Eurofins Scientific SE
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Regional Analysis
9.9.4 SWOT Analysis
9.10. Hologic, Inc.
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Segmental and Regional Analysis
9.10.4 Research & Development Expenses
9.10.5 Recent strategies and developments:
9.10.5.1 Acquisition and Mergers:
9.10.6 SWOT Analysis
Chapter 10. Winning Imperatives for Genomics In Cancer Care Market
Unique Offerings 